TSX closed
Loading markets…
Stocks

Why Avricore Health Inc stock is skyrocketing today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:AVCR.V

Follow AVCR

Photos provided by Pexels

Avricore Health Inc (AVCR.V) has seen a remarkable surge, gaining over 18% in just one trading day.

In a notable performance on the TSX Venture Exchange, Avricore Health Inc's stock price jumped by 18.18%, closing at CA$0.07. This surge comes amid ongoing developments in the company's expansion efforts and strategic initiatives.

Investor takeaway: Investors are responding positively to Avricore's strategic moves, particularly its focus on expanding the HealthTab™ network in the UK, which may enhance its market presence and revenue potential.

Avricore Health Inc

AVCR.V

Full stock page →

AVCR.V

Avricore Health Inc

Source:WealthAwesomeWealthAwesome
↓ $0.02 (-33.33%)
120 day period
$0.04$0.07$0.09Feb 13Jun 16Nov 5

Market cap

$6.32M

52W high

$0.10

52W low

$0.04

1W change

+11.11%

Beta

0.38

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on AVCR's historical volatility

HistoricalForecast68%95%
C$0.00C$0.16C$0.32C$0.47C$0.63C$0.79TodayApr 22Jul 14Nov 5Dec 18Jan 31Mar 15

30-Day Vol

228.4%

Annualized

90-Day Vol

170.6%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.05

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.05C$0.02 – C$0.11
60 trading daysC$0.05C$0.02 – C$0.15
90 trading daysC$0.05C$0.01 – C$0.20

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Stock Surges 18.18% in One Day

Avricore Health Inc's stock price increase reflects growing investor interest, possibly driven by expectations surrounding its expansion plans and recent financing activities.

Bull case

The recent financing efforts and strategic roadmap for UK expansion could lead to more pharmacies adopting Avricore's HealthTab™ platform. This growth potential might drive revenue up and boost investor confidence.

Bear case

Despite the positive momentum, the lack of immediate news or catalysts supporting the price increase raises questions about sustainability. Given the company's relatively small market cap of CA$6.95 million, any fluctuations could be significant.

Recent Performance Highlights

Avricore Health Inc's stock price rose by 18.18% in the last trading session, closing at CA$0.07. This surge is a significant indicator of investor sentiment, particularly as the company continues to focus on expanding its HealthTab™ platform in the UK.

Strategic Expansion Plans

The recent financing of CA$1.254 million aims to support Avricore's expansion of the HealthTab™ network. This strategic move is expected to enhance the company's market presence and could lead to increased revenue as the platform gains traction in community pharmacies.

Investor Sentiment and Market Outlook

While the current stock performance is promising, investors should remain cautious. The company's market cap of CA$6.95 million suggests that any fluctuations could be pronounced, and the sustainability of this price increase will depend on the successful execution of its expansion strategy.

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 30, 2026
Last Updated: October 23, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26